Mayo Clinic ECG-AI flags twice as many peripartum cardiomyopathy cases as routine care using portable stethoscope
“Mayo Clinic ECG-AI flags twice as many peripartum cardiomyopathy cases as routine care using portable stethoscope” documents a Diagnostics & Pathology deployment in Hospital & Health System at Mayo Clinic. newsnetwork.mayoclinic.org reports detection rate vs. routine care: 2x more cases flagged; this directory has not independently verified that result.
Evidence at a glance
- Evidence status:
- Automated evidence gate passed
- Deployment timeframe:
- Not reported by source
- Reported outcome metrics:
- 1 cited below
- Directory entry published:
- Source link checked:
The source-link check confirms reachability, not independent re-verification of every claim.
Source-reported figures — cited source: newsnetwork.mayoclinic.org
The Challenge
Peripartum cardiomyopathy — a weak heart pump occurring during or after pregnancy — is difficult to diagnose because its symptoms mimic normal pregnancy. Black women face up to a sixteenfold greater risk compared to white women, and underserved rural and urban populations worldwide lack access to cardiac diagnostics.
The Solution
Mayo Clinic developed an ECG-AI algorithm for 12-lead ECGs (FDA-cleared, licensed to Anumana) and a single-lead algorithm for AI-enabled digital stethoscopes (licensed to Eko Health) that captures ECG and heart sound recordings to predict low ejection fraction and flag peripartum cardiomyopathy.
Results
Research with obstetric patients in Nigeria demonstrated the AI-enabled digital stethoscope has the potential to flag twice as many cases of peripartum cardiomyopathy compared to routine care. The portable technology enables cardiomyopathy diagnostics in underserved urban and rural populations globally.
Key Takeaways
- Portable, single-lead ECG-AI can dramatically expand diagnostic reach in low-resource settings
- AI detection of a treatable condition like low ejection fraction must still be interpreted in clinical context
- Addressing health disparities requires tools that are inexpensive and widely deployable, not just accurate
Details
- Industry
- Hospital & Health System
- Use Case
- Diagnostics & Pathology
- AI Technology
- Computer-Aided Diagnosis
- Company Size
- Enterprise
- Company
- Mayo Clinic
- Evidence status
- Automated evidence gate passed
- Deployment timeframe
- Not reported by source
- Directory entry published
- Source link checked
Cited source
newsnetwork.mayoclinic.orgHave a similar implementation?
Share your customer's AI results and link it to your vendor profile.
Submit a case study →